Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
出版年份 2023 全文链接
标题
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy
作者
关键词
-
出版物
Substance Abuse
Volume 44, Issue 4, Pages 264-276
出版商
SAGE Publications
发表日期
2023-10-30
DOI
10.1177/08897077231203849
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Physician-Delegated Unobserved Induction with Buprenorphine in Pharmacies
- (2023) Traci C. Green et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
- (2023) Lauren J. Tanz et al. JAMA Network Open
- Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021
- (2023) Christopher M. Jones et al. JAMA Network Open
- Description and Evaluation of a Pilot Advanced Pharmacy Practice Experience in Addiction Medicine
- (2022) Lindsey J. Loera et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- Evaluation of patient satisfaction and perceptions of a long-acting injectable antipsychotic medication administration service in a community-based pharmacy during the COVID-19 pandemic
- (2022) Leighton N. Mascari et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Use of research evidence varied in efforts to expand specific pharmacist autonomous prescriptive authority: an evaluation and recommendations to increase research utilization
- (2022) Akshara Kumar et al. Health Research Policy and Systems
- State-level regulations and opioid-related health outcomes
- (2022) Joanna R. Jackson et al. DRUG AND ALCOHOL DEPENDENCE
- Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies
- (2022) Traci C. Green et al. Substance Abuse
- Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
- (2022) Lucas G. Hill et al. DRUG AND ALCOHOL DEPENDENCE
- Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis
- (2022) Lucas A. Berenbrok et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
- (2022) Noa Krawczyk et al. INTERNATIONAL JOURNAL OF DRUG POLICY
- Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists
- (2022) Lucas G. Hill et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician
- (2022) Adriane N. Irwin et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Readiness of community pharmacies to implement an opioid safety intervention
- (2022) Anthony S. Floyd et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Buprenorphine physician–pharmacist collaboration in the management of patients with opioid use disorder: results from a multisite study of the National Drug Abuse Treatment Clinical Trials Network
- (2021) Li‐Tzy Wu et al. ADDICTION
- Leveraging pharmacists to maintain and extend buprenorphine supply for opioid use disorder amid COVID-19 pandemic
- (2021) Alyssa M Peckham et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Wellness and Stigma: Pharmacy’s Ongoing Conflict
- (2021) Suzanne C. Harris et al. AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION
- The design and conduct of a randomized clinical trial comparing emergency department initiation of sublingual versus a 7-day extended-release injection formulation of buprenorphine for opioid use disorder: Project ED Innovation
- (2021) Gail D'Onofrio et al. Contemporary Clinical Trials
- Pharmacists’ stigma toward patients engaged in opioid misuse: When “social distance” does not mean disease prevention
- (2021) Amy Werremeyer et al. Substance Abuse
- Opioid treatment program and community pharmacy collaboration for methadone maintenance treatment: results from a feasibility clinical trial
- (2021) Li‐Tzy Wu et al. ADDICTION
- Access to medication-assisted treatment in the United States: Comparison of travel time to opioid treatment programs and office-based buprenorphine treatment
- (2021) Solmaz Amiri et al. DRUG AND ALCOHOL DEPENDENCE
- Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden
- (2021) Neda J. Kazerouni et al. DRUG AND ALCOHOL DEPENDENCE
- Alternative use of buprenorphine among people who use opioids in three U.S. Cities
- (2021) Priyal Gandhi et al. Substance Abuse
- Revisiting the X
- (2021) Elizabeth M. Ajazi et al. Journal of Addiction Medicine
- Pilot testing a tool to determine the costs and time associated with community pharmacy-based administration of injectable naltrexone
- (2021) James H. Ford et al. Research in Social & Administrative Pharmacy
- Telepharmacy during COVID-19: A Scoping Review
- (2021) Elizabeth J. Unni et al. Pharmacy
- Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment
- (2020) Elizabeth S. Davenport et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study
- (2020) Paul J. Joudrey et al. DRUG AND ALCOHOL DEPENDENCE
- Community pharmacist engagement in opioid use disorder prevention and treatment behaviors: A descriptive analysis
- (2020) Aaron Salwan et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic
- (2020) Gerald Cochran et al. Substance Abuse
- Methadone for Opioid Use Disorder—Decades of Effectiveness but Still Miles Away in the US
- (2020) Paul J. Joudrey et al. JAMA Psychiatry
- Reimbursement for pharmacist-provided health care services: A multistate review
- (2020) Elaine Nguyen et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Implementation of a pharmacist care manager model to expand availability of medications for opioid use disorder
- (2020) Beth M DeRonne et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Community pharmacy-based injectable naltrexone service delivery models and best practices
- (2020) James H. Ford et al. Research in Social & Administrative Pharmacy
- Strengthening the evidence-base on payment models for pharmacist-provided services
- (2019) Andy Stergachis JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- The Substance Use Intervention Team
- (2019) Hale M. Thompson et al. Journal of Addiction Medicine
- Making Amends for the Opioid Epidemic
- (2019) Joshua M. Sharfstein et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Access to Office-Based Buprenorphine Treatment in Areas With High Rates of Opioid-Related Mortality
- (2019) Tamara Beetham et al. ANNALS OF INTERNAL MEDICINE
- Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort
- (2019) Jake R. Morgan et al. DRUG AND ALCOHOL DEPENDENCE
- Interprofessional Substance Use Disorder Education in Health Professions Education Programs
- (2019) Andrew Muzyk et al. ACADEMIC MEDICINE
- Pharmacy: Addressing substance use in the 21st century
- (2019) Jeffrey Bratberg Substance Abuse
- Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality
- (2018) Marc R. Larochelle et al. ANNALS OF INTERNAL MEDICINE
- Applying American Society of Addiction Medicine Performance Measures in Commercial Health Insurance and Services Data
- (2018) Cindy Parks Thomas et al. Journal of Addiction Medicine
- Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
- (2018) C. Holly A. Andrilla et al. JOURNAL OF RURAL HEALTH
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial
- (2018) Joshua D Lee et al. LANCET
- Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees
- (2017) Amanda J. Abraham et al. HEALTH SERVICES RESEARCH
- An interprofessional education workshop to develop health professional student opioid misuse knowledge, attitudes, and skills
- (2017) Kristina Monteiro et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
- (2017) Luis Sordo et al. BMJ-British Medical Journal
- Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
- (2016) Yih-Ing Hser et al. ADDICTION
- Treatment utilization among persons with opioid use disorder in the United States
- (2016) Li-Tzy Wu et al. DRUG AND ALCOHOL DEPENDENCE
- Missed Opportunities for HIV Screening in Pharmacies and Retail Clinics
- (2016) Caitlin Dugdale et al. JOURNAL OF MANAGED CARE PHARMACY
- Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England
- (2015) Matthias Pierce et al. ADDICTION
- A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence
- (2015) Natasa Gisev et al. ADDICTION
- Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002–11
- (2015) Andrew W. Dick et al. HEALTH AFFAIRS
- Physician–pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients
- (2015) Bethany A. DiPaula et al. JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- Mental Health And Addiction Workforce Development: Federal Leadership Is Needed To Address The Growing Crisis
- (2013) Michael A. Hoge et al. HEALTH AFFAIRS
- Medication-Assisted Treatment With Methadone: Assessing the Evidence
- (2013) Catherine Anne Fullerton et al. PSYCHIATRIC SERVICES
- Medication-Assisted Treatment With Buprenorphine: Assessing the Evidence
- (2013) Cindy Parks Thomas et al. PSYCHIATRIC SERVICES
- Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care
- (2012) Bruce R. Schackman et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia
- (2010) B. Vicknasingam et al. DRUG AND ALCOHOL DEPENDENCE
- Long-term outcomes of office-based buprenorphine/naloxone maintenance therapy
- (2009) T.V. Parran et al. DRUG AND ALCOHOL DEPENDENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started